The Value of lncRNAs as a Biomarker for the Diagnosis of Gestational Diabetes: A Meta-Analysis
Der Wert von lncRNAs als Biomarker für die Diagnose von Gestationsdiabetes: eine Metaanalyse
Hormone and Metabolic Research · 01.01.2025 · 57 (01) · 67-74
DOI: 10.1055/a-2379-1326 ↗Auf einen Blick
Elf Artikel mit 12 Tests zeigen für lncRNAs bei Gestationsdiabetes eine hohe diagnostische Genauigkeit. Die klinische Nützlichkeit war jedoch niedrig.
Fragestellung
Welchen diagnostischen Wert haben lncRNAs für die Diagnose von Gestationsdiabetes?
Methode
Metaanalyse diagnostischer Studien; Suche in Embase, Medline, EBSCO, PubMed, CNKI und WanFang. Auswertung mit SROC, Forest Plots und Deeks’ Funnel Plot.
Ergebnisse
11 Artikel mit 12 Tests, 1060 GDM-Patientinnen und 1066 Kontrollen. AUC 0,89 (95 %-KI 0,86–0,92), Sensitivität 0,84 (95 %-KI 0,80–0,87), Spezifität 0,81 (95 %-KI 0,77–0,85). PLR 4,40; NLR 0,20; DOR 22,04.
Einschränkungen
Hohe Heterogenität; in Subgruppenanalysen nicht erklärbar.
Schlussfolgerung der Autor:innen
lncRNAs hatten eine hohe diagnostische Wertigkeit und gute Diskriminationsfähigkeit für GDM, die klinische Nützlichkeit war jedoch nicht hoch.
Kernaussagen
- AUC 0,89 (95 %-KI 0,86–0,92)
- Sensitivität 0,84 und Spezifität 0,81
- Hohe Heterogenität, klinische Nützlichkeit gering
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Metaanalyse in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.01.2025. Verfasst von Yang Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Ningxia, China. Hauptthemen laut MEDLINE: Biomarkers, Diabetes, Gestational, RNA, Long Noncoding. Die Arbeit nennt 32 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Gestational diabetes mellitus (GDM) is a common metabolic disorder in pregnancy and leads to serious harm to the mother and the fetus. A variety of lncRNAs play a key role in GDM. This meta-analysis was performed to explore the potential value of lncRNAs in GDM diagnosis. Articles correlated with lncRNA and GDM were screened from Embase, Medline, EBSCO, PubMed, Chinese National Knowledge Infrastructure, and WanFang databases. Summary receiver operator characteristic (SROC) was performed to evaluate the pooled area under curve (AUC). Forest plot was conducted to calculate the sensitivity, specificity, diagnostic likelihood ratio (LR), diagnostic score, and diagnostic odds ratio (DOR). Deeks’ funnel plot was utilized to evaluate the publication bias. Eleven articles containing 12 tests (1060 GDM patients and 1066 controls) were included in this meta-analysis. AUC (0.89, 95%CI=0.86–0.92), sensitivity (0.84, 95%CI=0.80–0.87), and specificity (0.81, 95%CI=0.77–0.85)of the SROC curve showed a high diagnostic value of lncRNA for GDM. Positive LR (PLR 4.40, 95%CI=3.45–5.60) and negative LR (NLR 0.20, 95%CI=0.15–0.26) results indicated that the diagnosis of lncRNA for GDM had low clinical utility. Diagnostic score (3.09, 95%CI=2.62–3.57) and DOR (22.04, 95%CI=13.68–35.51) results suggested lncRNAs have good discriminative effect on GDM. Heterogeneity was significantly higher, but not induced by the subgroups. LncRNAs had high diagnostic value and good discriminative effect for GDM, but the clinical utility was not high. This meta-analysis study offers a potential target for GDM diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- People's Hospital of Ningxia Hui Autonomous Region, Ningxia Medical University, Ningxia, China.
- Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China.
- General Practice, Hefei First People's Hospital, Hefei, China.
- Gynaecology and Obstetrics, The General Hospital of Western Theater Command PLA, Chengdu, China.
- Gynaecology and Obstetrics, Wuxi Maternity and Child Health Care Hospital (Affiliated Women's Hospital of Jiangnan University), Wuxi, China.
Zitieren
APA
Fan, Y., Chen, X., Yang, S., Tu, H., Zhang, Y., Wang, M., & Jiang, J. (2025). The Value of lncRNAs as a Biomarker for the Diagnosis of Gestational Diabetes: A Meta-Analysis. Hormone and Metabolic Research, 57(01), 67-74. https://doi.org/10.1055/a-2379-1326
Vancouver
Fan Y, Chen X, Yang S, Tu H, Zhang Y, Wang M, et al. The Value of lncRNAs as a Biomarker for the Diagnosis of Gestational Diabetes: A Meta-Analysis. Hormone and Metabolic Research. 2025;57(01):67-74. doi:10.1055/a-2379-1326
BibTeX
@article{Fan2025,
author = {Fan, Yang and Chen, Xin and Yang, Song and Tu, Hongxia and Zhang, Youyi and Wang, Mingyi and Jiang, Jingying},
title = {The Value of lncRNAs as a Biomarker for the Diagnosis of Gestational Diabetes: A Meta-Analysis},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {01},
pages = {67--74},
doi = {10.1055/a-2379-1326}
}
EUVIMED